This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas




What is Hyperprolactinaemia?

View general information including pathophysiology and etiology of hyperprolactinaemia

Learn more

Identifying Common Symptoms

Understand what signs to look for in hyperprolactinaemia and explore two patient case studies

Learn more

Interpreting Test Results

Recognise which tests to order for hyperprolactinaemia and what the results indicate

Learn more

Selecting Treatment Based on Guidelines

Determine therapy for hyperprolactinaemia based on clinical and patient factors

Learn more

Monitoring and Management

Know how to tailor hyperprolactinaemia therapy based on follow-up testing

Learn more
PP-UNP-GBR-0580. June 2022

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021



OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.

If you have already registered with and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.

Would you like to register or sign in now?